Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001213900-20-030687
Filing Date
2020-10-09
Accepted
2020-10-08 18:33:05
Documents
5

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM F-1 ea127980-f1a1_therapixbio.htm F-1/A 439508
2 FORM OF UNDERWRITING AGREEMENT BY AND AMONG THE COMPANY AND THE REPRESENTATIVE O ea127980ex1-1_therapixbio.htm EX-1.1 231007
3 FORM OF WARRANT ea127980ex4-5_therapixbio.htm EX-4.5 103631
4 CONSENT OF KOST, FORER, GABBAY & KASIERER, A MEMBER OF EY GLOBAL ea127980ex23-1_therapixbio.htm EX-23.1 2959
5 GRAPHIC image_001.jpg GRAPHIC 16194
  Complete submission text file 0001213900-20-030687.txt   800493
Mailing Address 16 ABBA HILLEL ROAD RAMAT GAN L3 5250608
Business Address 16 ABBA HILLEL ROAD RAMAT GAN L3 5250608 972-3-6167055
Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-248670 | Film No.: 201231765
SIC: 2834 Pharmaceutical Preparations